MindMaze Therapeutics Holding SA RLFTY
Set alert
0.18 USD 0.00 0.00%
At close · Oct 29
0.1779 Day range 0.1779
0.1677 52-week range 4.05
- YTD
- -93.69%
- 1 year
- -88.14%
- Open
- 0.1779
- Prev close
- 0.1779
- Mkt cap
- 30.24M
- Vol
- 2.50K
- Avg vol
- 83
- EPS
- -0.32
- P/E
- 0.00
More statistics
- Low
- 0.1779
- High
- 0.1779
2Y chart
Signals (19)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 4 days ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| RSI: Oversold | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Mar 27, 2026 | 7 months ago |
| RSI: Overbought | Mar 27, 2026 | 7 months ago |
| RSI: Oversold | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 17, 2026 | 8 months ago |
| RSI: Overbought | Jan 15, 2026 | 9 months ago |
News
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
- Relief Therapeutics Publishes 2025 Half-Year Report
- Relief Therapeutics Advances Publication of 2025 Half-Year Report
- Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze
- Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011
- Relief Therapeutics Announces Results of Annual General Meeting
- Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011
- Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
- Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
- Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011
Your note
Sign in to keep a note on RLFTY — it syncs with the Stock Master app.